Autophagy in immunity and inflammation
By Beth Levine, N. Mizushima, Herbert W. Virgin. Nature, 2011
3,180 citations recorded by the source corpus.
Autophagy is an essential, homeostatic process by which cells break down their own components. Perhaps the most primordial function of this lysosomal degradation pathway is adaptation to nutrient deprivation. However, in complex multicellular organisms, the core molecular machinery of autophagy — the 'autophagy proteins' — orchestrates diverse aspects of cellular and organismal responses to other dangerous stimuli such as infection. Recent developments reveal a crucial role for the autophagy pathway and proteins in immunity and inflammation. They balance the beneficial and detrimental effects of immunity and inflammation, and thereby may protect against infectious, autoimmune and inflammatory diseases.
Subfields: Epidemiology, Parasitology, Physiology
View Paper: https://www.semanticscholar.org/paper/345617d72ec440570517f06f825c10e9a961bdb4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Beth Levine
- Guido Kroemer
- Douglas R. Green
- N. Mizushima
- V. Deretic
- L. Galluzzi
- Alec C. Kimmelman
- I. Slaninová
In Parasitology
In Physiology
- Guido Kroemer
- Beth Levine
- Alec C. Kimmelman
- L. Galluzzi
- Douglas R. Green
- N. Mizushima
- V. Deretic
- D. Rubinsztein
Citations in the corpus
- The LIR motif – crucial for selective autophagy (2013, background): “…autophagy is highly relevant for a number of diseases, including cancer, neurodegenerative diseases, muscular dystrophy, lipidstorage disorders and processes such as development, ageing and innate immunity (Levine and Kroemer, 2008; Levine et al., 2011; Mizushima and Komatsu, 2011; Deretic, 2012).”
- Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. (2012, background): “Autophagy also coincides with the proteasomal degradation of sequestome-1 (p62/SQSTM1) which binds autophagic target proteins and LC3-II (160, 174, 342) (FIGURE 7).”
- Septins: the fourth component of the cytoskeleton (2012, background): “Diseases that are characterized by defective autophagy include cancer, neurodegenerative diseases, ageing, autoimmune diseases and inflammatory disease”
- New developments in goblet cell mucus secretion and function (2015, positive): “Autophagy is a ubiquitous cytoplasmic process in which a double-membrane autophagosome is formed and subsequently fused with lysosomes for degradation of enclosed components, a process linked to immunity and inflammation.(38) An autophagosome can also fuse with endosomes to form intermediate structu”
- Autophagy-Independent Functions of the Autophagy Machinery (2019, background): “Inflammation and Innate Immunity Bona fide autophagic responses mediate robust anti-inflammatory functions as they dispose of potential triggers of inflammation, including (but not limited to) cytosolic pathogens, micronuclei, and permeabilized mitochondria (Levine et al., 2011).”
- Regulation of inflammasome signaling (2012, background): “Regulation of inflammasome activation by autophagy Autophagy, an evolutionarily conserved catabolic process, facilitates the recycling of damaged cellular proteins and organelle”
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion (2018, background): “This process has been implicated in several pathologies, including cancer, lysosomal disorders, muscle dystrophies, neurodegeneration, and inflammatory diseases [1,4].”